Policy on booster, additional Covid vaccine doses in two weeks: NTAGI chief

The policy will deal with who will require the vaccine, when and how, NTAGI chief Dr N K Arora said

Coronavirus vaccine, Covid-19 vaccines

New Delhi
With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.
"National Technical Advisory Group on Immunisation (NTAGI) is coming up with a comprehensive policy on the booster and additional doses in the next two weeks. The policy will deal with who will require the vaccine, when and how. This needs to be seen in the context that a new variant is coming and with time only we will get to know more information about it. Therefore relevance and effectiveness of the current vaccines will also become apparent with time only," said Arora.
"There is a difference between booster dose and additional dose. A booster dose is given in a predefined period after two primary doses. Whereas, an additional dose is only given to those people who have problems with their immune function even after the primary doses. If a person's immune function is not appropriately built you give them an additional dose. So these are two different things," he added.
On the issue of vaccination of Children, Arora said, "As I have repeatedly been saying that children are our most important asset and we have developed a comprehensive plan for immunising our 44 crore children below the age of 18 years. A prioritisation process is also being built so that children with co-morbidities will be given priority and healthy children will be vaccinated. This plan will be made public very soon. ZyCoV-D , Covaxin, Corbevax and then mRNA vaccine are available for children and I will say it again that vaccines will be available in sufficient quantity for children also."
The Omicron variant (B.1.1.529), a new variant of the coronavirus, was first reported in Botswana on November 11, 2021, and appeared on November 14 in South Africa. It has been declared a variant of concern by the World Health Organisation (WHO).

Also Read

Monetary policy highlights: Growth not at pre-pandemic level yet, says RBI

Japan to start administering Covid vaccine booster doses from Dec 1

UK to roll out Covid-19 booster jabs for over-50s from next week

US expected to authorise mix-and-match Covid booster shots

RBI MPC highlights: 2nd wave has moderated; expect demand to pick up

'Long pending orders executed': Bharat Biotech resumes exports of Covaxin

Omicron: Covid testing must for arrivals in India from 'at-risk' countries

Delta variant still responsible for 99% of Covid cases globally: WHO

Omicron scare: Health officials searching for Botswana woman who visited MP

Thermo Fisher says its Covid-19 tests accurately detects Omicron variant

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Nov 29 2021 | 3:08 PM IST

Explore News